These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 19084210

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Optimal duration of anticoagulation of venous thromboembolism].
    Savina EN, Couturaud F.
    J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
    [Abstract] [Full Text] [Related]

  • 3. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F.
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Duration of anticoagulant therapy for patients with venous thromboembolism.
    Garcia D.
    Thromb Res; 2008 Dec; 123 Suppl 1():S62-4. PubMed ID: 18823648
    [Abstract] [Full Text] [Related]

  • 12. [Long-term treatment of venous thromboembolism].
    Meyer G, Couturaud F.
    Rev Prat; 2015 Feb; 65(2):208-13. PubMed ID: 25939225
    [Abstract] [Full Text] [Related]

  • 13. Duration of anticoagulant therapy after initial idiopathic venous thromboembolism.
    Frazee LA, Chomo DL.
    Ann Pharmacother; 2003 Oct; 37(10):1489-96. PubMed ID: 14519045
    [Abstract] [Full Text] [Related]

  • 14. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
    Kaatz S, Fu AC, AbuDagga A, LaMori J, Bookhart BK, Damaraju CV, Tan H, Schein J, Nutescu E.
    Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
    [Abstract] [Full Text] [Related]

  • 15. Extended therapy for primary and secondary prevention of venous thromboembolism.
    Conway SE, Marcy TR.
    J Pharm Pract; 2010 Aug; 23(4):313-23. PubMed ID: 21507831
    [Abstract] [Full Text] [Related]

  • 16. Long-term anticoagulation for venous thromboembolism: duration of treatment and management of warfarin therapy.
    Kearon C.
    Clin Chest Med; 2010 Dec; 31(4):719-30. PubMed ID: 21047578
    [Abstract] [Full Text] [Related]

  • 17. [Duration of antivitamin K therapy in venous thromboembolic disease].
    Ferrari E, Baudouy M, Morand P.
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1891-4. PubMed ID: 8729371
    [Abstract] [Full Text] [Related]

  • 18. Venous thromboembolism in nonagenarians. Findings from the RIETE Registry.
    Vasco B, Villalba JC, Lopez-Jimenez L, Falga C, Montes J, Trujillo-Santos J, Monreal M, RIETE Investigators.
    Thromb Haemost; 2009 Jun; 101(6):1112-8. PubMed ID: 19492156
    [Abstract] [Full Text] [Related]

  • 19. Prevention of deep vein thrombosis in cancer patients.
    Lee AY.
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [Abstract] [Full Text] [Related]

  • 20. [Current criteria to determine the duration of anticoagulant therapy].
    Palareti G.
    Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.